NHC director buys 949 shares in open market

NATIONAL HEALTHCARE CORP director Lisa Piercey reported an open‑market purchase of 949 shares of Common Stock at $184.2559 per share.

Rhea-AI Filing Summary

NATIONAL HEALTHCARE CORP director Lisa Piercey reported an open‑market purchase of 949 shares of Common Stock at $184.2559 per share. Following this transaction, she holds 949 Common shares directly. The filing also lists a 2026 stock option grant covering 7,500 underlying Common shares at a $171.42 exercise price, expiring on May 6, 2031, with a corrected expiration date noted for this option award.

Insights

Insider trading analyst

Director makes a modest open‑market share purchase and confirms existing option grant details.

Director Lisa Piercey bought 949 shares of NATIONAL HEALTHCARE CORP Common Stock in an open‑market purchase at $184.2559 per share. This is a straightforward buy transaction, with no related same‑day sales or derivative exercises disclosed.

The filing also shows a 2026 stock option grant on Common Stock with a $171.42 exercise price and May 6, 2031 expiration, referencing a prior inadvertent error in the reported expiration date. The option covers 7,500 underlying shares, which remain unexercised and held directly.

Insider Trade Summary

Net Buyer: 949 shares

Net Buy 2 txns

Insider Piercey Lisa

Role Director

Bought 949 shs ($175K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	949	$184.2559	$175K
holding	Option to Purchase Common Stock [2026 Grant]	--	--	--

Holdings After Transaction: Common Stock — 949 shares (Direct); Option to Purchase Common Stock [2026 Grant] — 7,500 contracts (Direct)

Footnotes (1)

1. F1. The exercise expiration date of these options were inadvertently reported incorrectly on the prior Form 4.

Key Figures

Shares purchased: 949 shares Purchase price: $184.2559 per share Common shares held: 949 shares +3 more

6 metrics

Shares purchased 949 shares Open‑market purchase of Common Stock

Purchase price $184.2559 per share Price paid for 949 Common shares

Common shares held 949 shares Total Common Stock following transaction

Option exercise price $171.42 per share 2026 option grant on Common Stock

Option underlying shares 7,500 shares Underlying Common shares for 2026 option grant

Option expiration date May 6, 2031 Corrected expiration for 2026 option grant

Key Terms

open-market purchase, Option to Purchase Common Stock, exercise price, expiration date, +1 more

5 terms

open-market purchase financial

"Purchase in open market or private transaction"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Option to Purchase Common Stock financial

"Option to Purchase Common Stock [2026 Grant]"

exercise price financial

"exercisePrice": "171.4200""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date": "2031-05-06T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

underlying Common shares financial

"underlying_security_shares": "7500.0000""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did NHC director Lisa Piercey do in this Form 4 filing?

Lisa Piercey reported buying 949 shares of NATIONAL HEALTHCARE CORP Common Stock. The shares were acquired in an open‑market purchase at $184.2559 per share, and she now directly holds 949 Common shares according to this filing.

At what price did Lisa Piercey buy NHC shares in the reported transaction?

She bought the NHC Common Stock shares at $184.2559 per share. The Form 4 describes the trade as an open‑market purchase of 949 shares, establishing both the transaction size and the per‑share price paid on the transaction date.

How many NATIONAL HEALTHCARE CORP shares does Lisa Piercey hold after this transaction?

After the reported transaction, she holds 949 shares of NHC Common Stock directly. The Form 4’s non‑derivative table lists 949 total shares following the open‑market purchase, indicating this is her reported direct Common Stock position.

What stock options for NHC does Lisa Piercey report in this Form 4?

She reports an option to purchase NHC Common Stock from a 2026 grant. The option has a $171.42 exercise price, covers 7,500 underlying Common shares, and carries an expiration date of May 6, 2031 as stated in the derivative holdings section.

Was there any correction or clarification about Lisa Piercey’s NHC stock options?

Yes. A footnote explains the option’s exercise expiration date had been inadvertently reported incorrectly previously. This filing states the corrected expiration date as May 6, 2031 for the 2026 grant covering 7,500 underlying Common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/02/2026 - 04:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Piercey Lisa

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TENNESSEE 37130

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		P		949	A	$184.2559	949	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock [2026 Grant]	$171.42							05/07/2026	05/06/2031(1)	Common Stock	7,500		7,500	D

Explanation of Responses:

1. The exercise expiration date of these options were inadvertently reported incorrectly on the prior Form 4.

	/s/ Lisa Piercey	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)